News from us and our partners

Tags

Topics

0 results

News
7 July, 2022
Genespire appoints Dr. Sabah Sallah as Chief Medical Officer
News
7 July, 2022
Biosyntia closes a €11.5 million round to launch world’s first bio-based vitamin B7
News
6 July, 2022
Nitrase Therapeutics expands leadership team with accomplished drug discovery and development executives
News
6 July, 2022
RefleXion announces closing of $125M debt facility for expanding cancer treatment
News
6 July, 2022
Skidmore, Owings & Merrill partners with Prometheus Materials to design zero-carbon building material
News
30 June, 2022
AAVantgarde announces the appointment of Naveed Shams, M.D., Ph.D. as Chief Development and Medical Officer
News
28 June, 2022
Inspirna to present Phase 1b RGX-202-01 clinical trial data at the 2022 ESMO World Congress on Gastrointestinal Cancer
News
22 June, 2022
Avantium and Carlsberg sign offtake agreement on PEF
News
16 June, 2022
GlycoEra AG announces appointment of Tanmoy Ganguly, Ph.D., as Chief Scientific Officer
News
8 June, 2022
Cédric Moreau discusses Apollo deal on "Journal des Biotechs"
News
7 June, 2022
Moon Surgical raises $31.3 million to accelerate development of Maestro Robotic System
News
6 June, 2022
Prometheus Materials raises $8 million to decarbonize the building materials industry, in Series A funding round led by Sofinnova Partners
News
2 June, 2022
EnginZyme and Tetra Pak join forces to advance sustainable food & beverage production
News
1 June, 2022
CinCor doses first patient in Phase 2 trial of baxdrostat
News
25 May, 2022
Henrijette Richter discusses Apollo deal with Børsen: "You have to play in that arena"
News
17 May, 2022
Graziano Seghezzi tells Unquote that after Apollo deal, "We will continue to build on our strategy"

Genespire appoints Dr. Sabah Sallah as Chief Medical Officer

Biosyntia closes a €11.5 million round to launch world’s first bio-based vitamin B7

Nitrase Therapeutics expands leadership team with accomplished drug discovery and development executives

RefleXion announces closing of $125M debt facility for expanding cancer treatment

Skidmore, Owings & Merrill partners with Prometheus Materials to design zero-carbon building material

AAVantgarde announces the appointment of Naveed Shams, M.D., Ph.D. as Chief Development and Medical Officer

Inspirna to present Phase 1b RGX-202-01 clinical trial data at the 2022 ESMO World Congress on Gastrointestinal Cancer￼

Avantium and Carlsberg sign offtake agreement on PEF

GlycoEra AG announces appointment of Tanmoy Ganguly, Ph.D., as Chief Scientific Officer

Cédric Moreau discusses Apollo deal on "Journal des Biotechs"

Moon Surgical raises $31.3 million to accelerate development of Maestro Robotic System

Prometheus Materials raises $8 million to decarbonize the building materials industry, in Series A funding round led by Sofinnova Partners

EnginZyme and Tetra Pak join forces to advance sustainable food & beverage production

CinCor doses first patient in Phase 2 trial of baxdrostat

Henrijette Richter discusses Apollo deal with Børsen: "You have to play in that arena"

Graziano Seghezzi tells Unquote that after Apollo deal, "We will continue to build on our strategy"

Inspirna to present Phase 1b RGX-202-01 clinical trial data at the 2022 ESMO World Congress on Gastrointestinal Cancer